Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase EARLY_PHASE1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 4Breast Neoplasms 3Uterine Cervical Neoplasms 1Uterine Cervical Dysplasia 1Triple Negative Breast Neoplasms 1Pain, Postoperative 1Nasopharyngeal Neoplasms 1Lymphoma, Follicular 1Localized Prostate Cancer 1Leukemia, Myeloid, Acute 1Insulin Resistance 1Infertility, Female 1Dementia 1Cognitive Dysfunction 1Carcinoma, Hepatocellular 1Arachnodactyly 1Alzheimer Disease 1

Interventions

Metformin 12Exercise 6Inositol 4High-Intensity Interval Training 3Ethinyl Estradiol 3Water 2Preoperative Exercise 2Insulin 2Cyproterone Acetate 2Acupuncture Therapy 2ziprasidone 1exendin (9-39) 1drospirenone and ethinyl estradiol combination 1drospirenone 1adrenosterone 1Telemedicine 1Tablets 1Sugars 1Standard of Care 1Resistance Training 1Pioglitazone 1Phlebotomy 1Olanzapine 1Magnesium Oxide 1Magnesium 1Ketones 1Human Growth Hormone 1Health Planning Guidelines 1Growth Hormone 1Folic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Insulin Resistance × Tablets × Clear all
NCT05951309 2023-07-19

Myoinositol Treatment and Asprosin Levels in PCOS

Near East University, Turkey

Phase NA Completed
30 enrolled

Insulin Resistance, Polycystic Ovary Syndrome, Arachnodactyly

Data powered by HemOnc (CC BY 4.0) Colophon âš¡